Catalyst Crew Technologies Corp. (OTC: CCTC) announced today the development and planned commercialization of an artificial intelligence-enabled healthcare analytics platform designed to assist healthcare providers in analyzing patient data, identifying clinical risks, and supporting informed medical decision-making.
The AI Healthcare Platform integrates multiple data inputs, including medical records, diagnostic data, and patient-reported information, to generate insights intended to help healthcare professionals evaluate patient conditions and coordinate care. The company believes such AI-enabled analytics technologies can improve efficiency across healthcare systems, particularly in emerging markets where access to specialized medical resources may be limited.
The platform is a core component of the company's broader digital health ecosystem, which also includes a technology-enabled healthcare services coordination platform supporting telehealth infrastructure, remote patient monitoring, and hybrid home-based medical services. Catalyst Crew intends to integrate the AI Healthcare Platform across its existing and planned healthcare infrastructure initiatives, positioning it as a core technology layer for data analysis, care coordination, and clinical decision-support.
Catalyst Crew Technologies is prioritizing market development in Latin America, where the company sees significant opportunity for digital health innovation. The region's healthcare systems are increasingly seeking scalable technology solutions to improve diagnostic capabilities and support remote patient care. According to the company, AI-enabled healthcare technologies may help expand access to medical expertise and improve overall system efficiency.
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated, “Artificial intelligence has the potential to transform how healthcare providers analyze clinical information and coordinate patient care. Our goal is to develop scalable technology platforms that can assist medical professionals in improving efficiency, expanding access to care, and supporting better healthcare outcomes.”
The company intends to continue developing and refining its healthcare technology platforms and evaluating opportunities for strategic partnerships, pilot deployments, and market expansion initiatives. More information is available at https://catalystcrewai.com and in the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
